Connect with us

Press Releases

Prevent Blindness President & CEO Jeff Todd to Lead 2024 National Health Council Board of Directors

Jeff Todd, president & chief executive officer of Prevent Blindness, was named the Chair of the NHC Board of Directors for 2024.

mm

Published

on

Prevent Blindness President & CEO Jeff Todd to Lead 2024 National Health Council Board of Directors

Jeff Todd, president and CEO, Prevent Blindness and 2024 board chair, National Health Council

(PRESS RELEASE) WASHINGTON, DC – At its annual membership meeting, the National Health Council (NHC) elected its officers and Board of Directors members for 2024. Jeff Todd, president & chief executive officer of Prevent Blindness, was named the Chair of the NHC Board of Directors for 2024. Other members of the Executive Committee are: Chair Elect Schroeder Stribling, President & Chief Executive Officer, Mental Health America; Vice Chair Michael Osso, President & Chief Executive Officer, Crohn’s & Colitis Foundation; SecretarySue Peschin, President & Chief Executive Officer, Alliance for Aging Research; Treasurer Harold Wimmer, National President & Chief Executive Officer, American Lung Association; and Immediate Past Chair Kenny Mendez, President & Chief Executive Officer, Asthma & Allergy Foundation of America.

“Jeff Todd is an excellent choice to lead our Board in 2024,” said Randall Rutta, the NHC’s chief executive officer. “His experience, expertise and commitment to advancing equitable access to health care will serve us well as we navigate the complex political, societal, and technological changes that lie ahead for the patient communities we serve.”

Seven new members are joining the 2024 NHC Board of Directors: Charles Henderson, Chief Executive Officer, American Diabetes Association; Louise Vetter, President & Chief Executive Officer, Huntington’s Disease Society of America; Jorey Berry, President & Chief Executive Officer, Immune Deficiency Foundation; Kathryn G. Schubert, President & Chief Executive Officer, Society for Women’s Health Research; Michael Ybarra, MD, Chief Medical Officer, PhRMA; Sunita Mishra, MD, Chief Medical Officer, Amazon Health Services; and Michele M. Oshman, Vice President, External Affairs, Biotechnology Innovation Organization (BIO).

These new members join current Board members re-elected to new three-year terms: Mendez; Osso; Stribling;Wimmer; and Julie Gerberding, MD, Chief Executive Officer, Foundation for the National Institutes of Health.

Advertisement

Advertisement

Advertisement

Advertisement

Subscribe

INVISIONMAG.COM
BULLETINS

Get the most important news and business ideas for eyecare professionals every weekday from INVISION.

Instagram

Most Popular